Your browser doesn't support javascript.
loading
Tranexamic Acid, Mortality, and Intracranial Hemorrhage Type in Moderate or Severe Traumatic Brain Injury.
McKinley, W Ian; Rowell, Susan E; Mansour, Ali; Hoefer, Lea; Polcari, Ann; Schreiber, Martin; Benjamin, Andrew J.
Affiliation
  • McKinley WI; The University of Chicago, Chicago, Illinois.
  • Rowell SE; The University of Chicago, Chicago, Illinois.
  • Mansour A; The University of Chicago, Chicago, Illinois.
  • Hoefer L; The University of Chicago, Chicago, Illinois.
  • Polcari A; The University of Chicago, Chicago, Illinois.
  • Schreiber M; Oregon Health & Science University, Portland.
  • Benjamin AJ; The University of Chicago, Chicago, Illinois.
JAMA Surg ; 158(11): 1222-1224, 2023 Nov 01.
Article in En | MEDLINE | ID: mdl-37755726
This cohort study examines the association of tranexamic acid administration with intracranial hemorrhage type, neurologic outcomes, and mortality in patients with traumatic brain injury.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tranexamic Acid / Brain Injuries, Traumatic / Antifibrinolytic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Surg Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tranexamic Acid / Brain Injuries, Traumatic / Antifibrinolytic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Surg Year: 2023 Document type: Article